Mustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme February 20, 2019 - NASDAQ Companies 0 » View More News for February 20, 2019